ArticleClinical neurology and neurosurgery2016

The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma.

Paolo Tini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.